Common use of Continued Monitoring and Data Maintenance Clause in Contracts

Continued Monitoring and Data Maintenance. Upon receipt of notice of termination by Sponsor, Institution and Investigator will terminate enrollment or randomization and will terminate treatment of all Trial Participants pursuant to the Protocol, except if the safety of such Trial Participants could be endangered or if the Institution and Investigator are otherwise instructed by Sponsor. Following such termination, Institution and Investigator will continue to monitor Trial Participants and maintain clinical data as set forth in the Protocol and in accordance with ICH GCP.

Continued Monitoring and Data Maintenance. Upon receipt of notice of termination by Sponsor, Institution Provider and Investigator will terminate enrollment or randomization and will terminate treatment of all Trial Participants pursuant to the Protocol, except if the safety of such Trial Participants could be endangered or if the Institution Provider and Investigator are otherwise instructed by Sponsor. Following such termination, Institution Provider and Investigator will continue to monitor Trial Participants and maintain clinical data as set forth in the Protocol and in accordance with ICH GCP.

Continued Monitoring and Data Maintenance. Upon receipt of notice of termination by Sponsor, Institution and Investigator will terminate enrollment or randomization and will terminate treatment of all Trial Participants pursuant to the Protocol, except if the safety of such Trial Participants could be endangered or if the Institution and Investigator are otherwise instructed by Sponsor. Following such termination, Institution and Investigator will continue to monitor Trial Participants and maintain clinical data as set forth in the Protocol and in accordance with ICH GCP.. 15.7.2

Continued Monitoring and Data Maintenance. Upon receipt of notice of termination by Sponsor, Institution and Investigator will terminate enrollment or randomization and will terminate treatment of all Trial Participants pursuant to the Protocol, except if the safety of such Trial Participants could be endangered or if the Institution and Investigator are otherwise instructed by Sponsor. Following such termination, Institution and Investigator will continue to monitor Trial Participants and maintain clinical data as set forth in the Protocol and in accordance with ICH GCP.. 14.10 Účinky ukončení. Jakékoli takové ukončení může mít tyto účinky: 14.10.1

Continued Monitoring and Data Maintenance. Upon receipt of notice of termination by Sponsor, Institution and Investigator will terminate enrollment or randomization and will terminate treatment of all Trial Participants pursuant to the Protocol, except if the safety of such Trial Participants could be endangered or if the Institution and Investigator are otherwise written instructed by Sponsor. Following such termination, Institution and Investigator will continue to monitor Trial Participants and maintain clinical data as set forth in the Protocol and in accordance with ICH GCPGCP and Applicable Laws.

Continued Monitoring and Data Maintenance. Upon receipt of notice of termination by Sponsor, Institution Provider and Investigator will terminate enrollment or randomization and will terminate treatment of all Trial Participants pursuant to the Protocol, except if the safety of such Trial Participants could be endangered or if the Institution Provider and Investigator are otherwise instructed by Sponsor. Following such termination, Institution Provider and Investigator will continue to monitor Trial Participants and maintain clinical data as set forth in the Protocol and in accordance with ICH GCP.in